GlassScriptPhysician profile
Matthew G Freeman
NPI 1750482477
$711.86
in general payments reported to CMS, 2019-2025
7 companies · $98.63 in 2025
The $98.63 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $120 · 2021: $227 · 2022: $183 · 2023: $58.84 · 2024: $24.44 · 2025: $98.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161 · Education: $20.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $161.39 |
| Education | $20.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $264.80 | 2020-2021 | |
| Abbvie INC. | $187.44 | 2021-2025 | |
| Medtronic, INC. | $89.84 | 2022 | |
| Abbott Laboratories | $65.40 | 2022-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $44.98 | 2023 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $34.84 | 2022-2025 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $24.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.